Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pravin Dinkar, Supe"'
Autor:
Indraneel Basu, Manish Agarwal, Viral Shah, Vijay Shukla, Sunil Naik, Pravin Dinkar Supe, Manoj Kumar Srivastava, Kanakapura Vrushabaiah Giriraja, Peersab Pinjar, Pradeep Kumar Mishra, Shishir Joshi, Ranjit Vijayakumar, Serge van de Witte
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 1, Pp 1-10 (2022)
Background This study was conducted to compare the immunogenicity and safety profile of two quadrivalent influenza vaccines (QIVs) in healthy adults (18–60 years) and elderly (>61 years) participants. Method This phase III study was conducted from
Externí odkaz:
https://doaj.org/article/0fc3b0b843a84b378263238aaeb5ba5a
Autor:
Shishir Joshi, Manish Agarwal, Kanakapura Vrushabaiah Giriraja, Pradeep Kumar Mishra, Sunil Naik, Vijay K. Shukla, Indraneel Basu, Pravin Dinkar Supe, Serge van de Witte, Ranjit Vijayakumar, Peersab M Pinjar, Manoj K. Srivastava, Viral Shah
Publikováno v:
Human vaccinesimmunotherapeutics. 18(1)
Background: This study was conducted to compare the immunogenicity and safety profile of two quadrivalent influenza vaccines (QIVs) in healthy adults (18-60 years) and elderly (>61 years) participants.Method: This phase III study was conducted from M
Publikováno v:
The Journal of the Association of Physicians of India. 68(1)
Autor:
Pravin Dinkar Supe, Mark Cutler, Bhagirath B. Solanki, Vani Sundaraiyer, Christine Juergens, Daniel A. Scott, Beate Schmoele-Thoma, Manojkumar B. Chopada, Natacha Le Dren-Narayanin, William C. Gruber
Publikováno v:
Human Vaccines & Immunotherapeutics. 13:2065-2071
Streptococcus pneumoniae infection is a major global public health concern in older adults, especially as life expectancy continues to increase in most countries, including India. Recently, a 13-valent pneumococcal conjugate vaccine (PCV13) with the